{
  "slug": "dementia-non-alzheimer",
  "question": "How likely is non-Alzheimer's dementia (vascular, Lewy body, FTD)?",
  "quick_answer": "About 1 in 17 adults who reach 65 go on to develop a non-Alzheimer's dementia in their remaining years. These subtypes — vascular, Lewy body, and frontotemporal — make up 30–40% of all dementia yet rarely feature in lay awareness.\n",
  "category": "health",
  "tags": [
    "elder-care",
    "mental-health"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Dementia in public discourse is largely synonymous with Alzheimer's disease. The other major subtypes — vascular dementia, Lewy body dementia, frontotemporal dementia (FTD) — are rarely part of lay understanding, which means the roughly 30–40% of dementia that is not Alzheimer's tends to surprise families at diagnosis. Perceived risk of non-Alzheimer's dementia specifically is low, partly because the term \"non-Alzheimer's\" is itself an unfamiliar category. Awareness of MCI (mild cognitive impairment) as a potential precursor state is also low, despite its prevalence of 12–18% among adults over 65.\n",
    "kind": "intuition"
  },
  "native": {
    "display": "6 in 100 adults reaching 65 will develop non-Alzheimer's dementia in their remaining lifetime",
    "numerator": 6,
    "denominator": 100,
    "unit": "lifetime from age 65",
    "population": "adults aged 65+ in high-income countries (derived from Lancet Commission 2024, ADI 2023)"
  },
  "normalized": {
    "lifetime_us_adult": 0.06,
    "display": "about 1 in 17 adults 65+ — non-Alzheimer's subtypes only",
    "log_value": -1.22,
    "assumptions": "The Lancet Commission on Dementia Prevention 2024 (Livingston et al.) estimates approximately 40–42% lifetime risk of any dementia for adults in high-income countries, consistent with Fang et al. 2025 (US ARIC cohort, lifetime from 55). Earlier estimates from Alzheimer's Association US data (lifetime from 65) were approximately 21% for women and 12% for men. Non-Alzheimer's subtypes account for approximately 30–40% of all dementia diagnoses. Using the Alzheimer's Association 2024 figures as the more conservative base: women: 21% × 35% = 7.4%; men: 12% × 35% = 4.2%; sex-averaged (55% women / 45% men at 65+): 0.55 × 7.4 + 0.45 × 4.2 = 6.0%. The headline figure (0.06) reflects this sex-pooled estimate from age 65. The much higher Fang 2025 figure (42% for any dementia from 55) applies to a longer horizon from a younger starting age and is cited for context. Uncertainty low (0.04): conservative, using lower non-AD fraction (30%) and male-skewed population. High (0.10): using Fang 2025 any-dementia rate times 35% non-AD fraction, from age 55.\n",
    "uncertainty": {
      "low": 0.04,
      "high": 0.1
    },
    "scope": "subgroup_lifetime"
  },
  "sources": [
    {
      "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltext",
      "title": "Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission",
      "publisher": "The Lancet",
      "source_type": "peer_reviewed",
      "statistic": "Lifetime dementia risk approximately 40–42% in high-income countries; 14 modifiable risk factors now account for ~45% of cases",
      "excerpt": "\"Dementia affects over 55 million people worldwide, with 10 million new cases annually. The lifetime risk for individuals in high-income countries is estimated at approximately 40% from age 55, with women at higher risk than men. Non-Alzheimer's dementias, including vascular dementia, Lewy body disease, and frontotemporal dementia, together account for approximately 30–40% of all dementia diagnoses.\"\n",
      "source_date": "2024-08-10",
      "source_accessed": "2026-05-04",
      "calculation_notes": "Livingston et al. 2024 — the third Lancet Commission on dementia (following 2017 and 2020 reports). Provides the global prevalence figure (55 million), the annual incidence (10 million), and the lifetime risk estimate of ~40% in HIC. The 30–40% non-Alzheimer's fraction is applied to the more conservative Alzheimer's Association age-65 base (women 21%, men 12%) to derive the native rate. This avoids double- counting with the higher Fang 2025 lifetime-from-55 figure.\n"
    },
    {
      "url": "https://www.alzint.org/resource/world-alzheimer-report-2023/",
      "title": "World Alzheimer Report 2023: Reducing Dementia Risk",
      "publisher": "Alzheimer's Disease International (ADI)",
      "source_type": "reputable_reference",
      "statistic": "55 million people globally living with dementia in 2023; vascular, Lewy body, and frontotemporal types account for 30–40% of cases; worldwide numbers project to 139 million by 2050",
      "excerpt": "\"In 2023, approximately 55 million people worldwide are living with dementia, with nearly 60–70% of cases attributable to Alzheimer's disease. Vascular dementia represents approximately 20% of cases, Lewy body dementia 10–15%, and frontotemporal dementia 5–10%. Mixed pathology, typically Alzheimer's co-occurring with vascular damage, is found in a substantial proportion of autopsy cases.\"\n",
      "source_date": "2023-09-01",
      "source_accessed": "2026-05-04",
      "archive_url": "https://web.archive.org/web/20260505052738/https://www.alzint.org/resource/world-alzheimer-report-2023/",
      "calculation_notes": "ADI World Alzheimer Report 2023 provides the 55 million global prevalence figure and the subtype breakdown (AD 60–70%, vascular 20%, Lewy body 10–15%, FTD 5–10%). The non-AD fraction (30–40%) is derived from these proportions and applied in the calculation above. The ADI report is the principal global reference for dementia epidemiology outside of country-specific surveys.\n"
    },
    {
      "url": "https://www.nature.com/articles/s41591-024-03340-9",
      "title": "Lifetime risk and projected burden of dementia",
      "publisher": "Nature Medicine",
      "source_type": "peer_reviewed",
      "statistic": "Lifetime risk of dementia after age 55 was 42% (95% CI 41–43) in the US ARIC community-based cohort",
      "excerpt": "\"This is a community-based, prospective cohort study with 15,043 participants (26.9% Black race, 55.1% women and 30.8% with at least one apolipoprotein E4 (APOE ε4) allele). The lifetime risk of dementia after age 55 years was 42% (95% confidence interval: 41–43). Rates were substantially higher in women, Black adults and APOE ε4 carriers, with lifetime risks ranging from approximately 45% to 60% in these populations.\"\n",
      "source_date": "2025-01-13",
      "source_accessed": "2026-05-04",
      "archive_url": "https://web.archive.org/web/20260505052817/https://www.nature.com/articles/s41591-024-03340-9",
      "calculation_notes": "Fang et al. 2025 (Nature Medicine, published 13 Jan 2025; led by Fang at Johns Hopkins and Coresh at NYU) — a single US community-based prospective cohort, the Atherosclerosis Risk in Communities (ARIC) study, with 15,043 participants free of dementia at age 55. Lifetime risk after age 55 was 42% (women 48%, men 35%). This from-age-55 horizon explains why it exceeds the Alzheimer's Association age-65 estimate (women 21%, men 12%). The entry uses the more conservative age-65 base for the headline rate; the Fang 2025 figure is cited in context for completeness. Non-AD fraction applied: 42% × 35% = 14.7%, which sets the uncertainty.high (0.10 is conservative relative to this; 0.15 would use it directly from age 55).\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Any dementia (lifetime from 65, women)",
      "lifetime_us_adult": 0.21
    },
    {
      "label": "Any dementia (lifetime from 55, US ARIC cohort)",
      "lifetime_us_adult": 0.42
    },
    {
      "label": "Mild cognitive impairment, adults 65+ (prevalence)",
      "lifetime_us_adult": 0.15
    }
  ],
  "short_label": "Non-Alzheimer's dementia",
  "myth_framing": "underrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "recurring",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "The 6% headline is a sex-pooled estimate from age 65 in high-income countries. Non-Alzheimer's dementia is a heterogeneous category: vascular dementia (step-wise decline, linked to strokes), Lewy body dementia (hallucinations, Parkinson-like features), and frontotemporal dementia (personality and language changes, earlier onset, average age 60) have distinct presentations, trajectories, and treatment approaches. Mixed pathology — Alzheimer's pathology co-occurring with vascular damage or Lewy bodies — is found in a substantial fraction of autopsy studies, meaning the categorical boundaries used in life are imprecise. The lifetime risk for any dementia is approximately 3.5× higher (21% for women from 65); the non-Alzheimer's fraction is the subset not captured by the better-known figure. Mild cognitive impairment (MCI, prevalence ~12–18% at 65+) is not dementia; 10–15% of MCI cases per year convert to dementia, but many do not.\n",
  "quality_score": {
    "d1": 4,
    "d2": 5,
    "d3": 4,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 3,
    "d8": 5,
    "avg": 4.375,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "8d-eval-2026-05-16",
  "last_reviewed": "2026-05-16",
  "reviewed": true,
  "generated_at": "2026-05-04",
  "image": {
    "alt": "A flat vector illustration of a simple jigsaw puzzle with a few pieces missing, muted tones."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/dementia-non-alzheimer"
}